MT-5547
MT-5547-J01
Phase 3 small_molecule completed
Quick answer
MT-5547 for Osteoarthritis, Knee / Osteoarthritis, Hip is a Phase 3 program (small_molecule) at Tanabe Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tanabe Pharma
- Indication
- Osteoarthritis, Knee / Osteoarthritis, Hip
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed